Systems biology has described ''small'' systems in great detail and with great success, with the yeast galactose system and the eukaryotic cell cycle being two key examples. In my mind, the biggest challenge now is how do we phrase questions and design and interpret experiments that will illuminate how complexity is achieved in larger systems? As the physicist P.W. Anderson aptly wrote in 1972, ''more is different.'' This idea implies that entirely new concepts will emerge from studying increasingly large systems. For each system, whether an organelle, unicellular organism, metazoan, or plant, we need to define its components and the interactions between them, as well as formulate conceptual frameworks that will help us understand how complexity is achieved, not only by deriving basic design principles, but by truly understanding how simple building blocks function together in a dynamic manner in space and time. This requires the continuous development and application of unbiased and highthroughput technologies to define and perturb large biological systems. A deep and comprehensive knowledge of the way that systems develop and maintain homeostasis and respond to outside cues or insults will ultimately be essential to understand how systems go awry during aging and in disease.
Quality Trumps Quantity
Rudolf Aebersold
ETH Zurich
There is a general sentiment among biologists that we are drowning in data, courtesy of high-throughput technologies in genomics, proteomics, metabolomics, lipidomics, and live cell imaging, with each approach generating terabytes of data per lab. So it may at first seem paradoxical that one of the big challenges for systems biology is the creation of highquality data sets. A general roadmap for studies in systems biology that I and colleagues have promoted consists of making a series of targeted perturbations in a given system and quantifying the molecular changes that result. The data obtained from multiple, sequential cycles of perturbation and measurement support the generation and refinement of mathematical models describing the dynamic behavior of the system, thus increasing biological understanding. However, for this approach to work, data quality is much more important than data quantity. Data sets useful for systems biology need to quantify each component of the system in each perturbed state with minimal error; meaning, the data sets need to be quantitative, accurate, reproducible, and complete. With the exception of transcription profiling, data sets with these attributes are rare. Fortunately, techniques are advancing at a rapid pace. In particular, new mass spectrometric approaches that accurately quantify predetermined sets of molecules (proteins, phosphoproteins, metabolites, lipids) at very high sensitivity, reproducibility, and dynamic range seem poised to alleviate systems biology's hunger for high-quality data sets.
Tools, Archives, and Models

Tobias Meyer
Stanford University Medical School
The field faces three major challenges. First, new tools are needed to systematically perturb and monitor signaling processes and functions in both cells and organisms. This requires innovators with engineering and chemistry backgrounds to develop chemical and optical methods to perturb and monitor complex systems as well as improvements in image analysis to facilitate the extraction of quantitative data. Second, large data sets are needed to create interaction maps linking genes to each other and to their biological functions. A big challenge is to organize and interpret the information being generated. This requires computationally skilled biologists with a mindset of librarians to not only generate data, but to also preserve and update data sets. Third, the ultimate goal is generating quantitative models that link genes, proteins, and other biomolecules to cellular and organismal function. The big challenge here is to start with draft models, typically described by differential equations, to propose the most informative perturbation tools and biosensors to then generate new data sets that can, in turn, be used to improve the underlying theory. Systems biology is a quest for finding such converging loops between theory and experiments. This requires a new breed of researchers with detailed knowledge of organismal, cellular, and molecular mechanisms and mathematical expertise, as well as creative ideas for how to attack these issues.
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Consider Context
Peer Bork
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The amount of data being produced to study biological systems at various scales, from molecules to ecosystems, is growing exponentially, and handling this data from local production to its storage in publicly accessible and integratable depositories poses technical challenges that some areas of biology are already confronting. But the conceptual challenges ahead may be even more daunting. A major one is quantifying the impact of context, that is, experimental constraints and environmental factors that influence results. Internal and environmental properties together characterize biological systems, exemplified by human diseases, which are affected by complex genetic and environmental components, the latter being barely understood and still frequently neglected in current studies. Another challenge is how much we can abstract from observations derived from cultivated cell lines, given the absence of a native tissue context? Many current technologies impose noise onto real biological signals (for instance, studying cell populations rather than individual cells is frequently unavoidable), and given the complexity of biological systems in terms of their many interacting elements and confounding variables, how are we to estimate which aspects of a finding remain valid in other settings? Thus, there is an urgent need for generalized formal descriptions of the state and the environmental context of biological systems (metadata), which would not only improve the reproducibility and comparability of observations, but would also enable strategies for quantifying the impact of environmental conditions. Such efforts will help to minimize data overinterpretation (as can easily occur with indirect correlations) and reduce the accumulation of misleading results.
Systems Pharmacology
Marc W. Kirschner
Harvard University
It is in pharmacology that systems biology may face its most practical challenge and opportunity. Although everyone might grant that drug action is both a quantitative and multicomponent problem, the targets of drugs are not pathways, but individual proteins. Hence, the question naturally arises: If the ultimate targets of drugs are products of individual genes, are the qualitative pictures that we currently derive from biochemistry and genetics sufficiently informative to allow those targets to be identified effectively? Or could the process be facilitated by a quantitative understanding of the dynamics of the pathways at a high level of integration? We can all grant that high-level integration exists without agreeing that analyzing it quantitatively will dramatically increase efficiency in the high-stakes search for new and better medicines. We should soon know the answer, however, because approaches for understanding pathways derived from systems biology will certainly merge with more traditional areas of pharmacology, if for no other reason than that present approaches are often unproductive. But it would be wrong to think of systems biology just as a set of tools to bring to pharmacology. Systems biology is invading virgin intellectual territory, much as molecular biology and cell biology did before. And this brash invasion has already begun to raise new questions, pose testable hypotheses, and question long-held beliefs. It will transform how we understand biological behavior. Quantitative and broad knowledge from systems biology, more than just its new tools, could soon bring major new insights to physiology and pharmacology.
